What does it take to stay healthy past 100?: Commentary on "No disease in the brain of a 115-year-old woman"
- PMID: 18524418
- PMCID: PMC2493610
- DOI: 10.1016/j.neurobiolaging.2008.04.011
What does it take to stay healthy past 100?: Commentary on "No disease in the brain of a 115-year-old woman"
Abstract
The description of an 115-year-old woman without dementia or Alzheimer's disease (AD) is remarkable, but fits well with previous accounts of aging and AD. Several similar non-demented cases aged 85-105 years have been reported previously, who had neurofibrillary tangles in the medial temporal lobe, but no deposition of amyloid plaques. Together with observations on other aging and very mild AD cases, these can be related to a model of aging and AD. In this model, tangles develop independently but relatively slowly during aging; these represent neurodegeneration, but by themselves may not represent AD. In contrast, amyloid may be the driving factor in AD, exacerbating neurofibrillary changes and other neurodegeneration. There is a pre-clinical period when the process has begun but has not produced sufficient degeneration to produce clinical symptoms. Critical questions raised by the present report include what genetic or other factors allowed healthy survival to age 115 year, and whether anti-amyloid therapies will allow more general survival in good mental health beyond age 100?
Conflict of interest statement
Disclosure Statement: There are no actual or potential conflicts of interest to report.
Comment on
-
No disease in the brain of a 115-year-old woman.Neurobiol Aging. 2008 Aug;29(8):1127-32. doi: 10.1016/j.neurobiolaging.2008.04.010. Epub 2008 Jun 4. Neurobiol Aging. 2008. PMID: 18534718
References
-
- Arrigada PV, Marzloff K, Hyman B. Distribution of Alzheimer type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer’s disease. Neurology. 1992;42:1681–1688. - PubMed
-
- Bales KR, Dodart JC, DeMattos RB, Holtzman DM, Paul SM, Apolipoprotein E. amyloid, and Alzheimer disease. Mol Interv. 2002;2(6):363–75. - PubMed
-
- Brendza RP, Holtzman DM. Amyloid-beta immunotherapies in mice and men. Alzheimer Dis Assoc Disord. 2006;20(2):118–23. - PubMed
-
- Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997 Jul-Aug;18(4):351–7. - PubMed
-
- Duyckaerts C, Hauw JJ. Prevalence, incidence and duration of Braak’s stages in the general population: can we know? Neurobiol Aging. 1997 Jul-Aug;18(4):362–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
